The Soluble α Chain of Interleukin-15 Receptor: A Proinflammatory Molecule Associated with Tumor Progression in Head and Neck Cancer - Archive ouverte HAL Access content directly
Journal Articles Cancer Research Year : 2008

The Soluble α Chain of Interleukin-15 Receptor: A Proinflammatory Molecule Associated with Tumor Progression in Head and Neck Cancer

(1, 2, 3) , (4) , (2, 1) , (4) , (5) , (6) , (2, 6) , (7) , (8, 9) , (3) , (10) , (4) , (4) , (2, 1) , (6) , (3) , (4) , (2, 6, 1)
1
2
3
4
5
6
7
8
9
10
Wolf Hervé Fridman
  • Function : Author
  • PersonId : 899103
Daniel Brasnu
  • Function : Author
  • PersonId : 844077

Abstract

Interleukin (IL)-15 is a proinflammatory cytokine, as it induces the production of inflammatory cytokines [IL-6, tumor necrosis factor α (TNFα), IL-17, etc.]. A correlation between high intratumoral IL-15 concentrations and poor clinical outcome in lung and head and neck cancer patients has been recently reported. The purpose of this study was to investigate the role of the soluble α chain of IL-15 receptor (sIL-15Rα), a natural regulator of IL-15, in head and neck cancer. Fifty-three newly diagnosed untreated head and neck cancer patients were included in this study. Quantification of sIL-15Rα was performed with a newly developed RIA. Increased serum sIL-15Rα concentrations were found in head and neck cancer patients and were closely correlated with poor clinical outcome both in terms of locoregional control and survival even on multivariate analysis. sIL-15Rα was mainly produced by tumor cells via proteolytic cleavage of IL-15Rα mediated by ADAM-17. A correlation was observed between ADAM-17 expression in tumor cells and serum sIL-15Rα concentrations. Surprisingly, sIL-15Rα did not act in vitro as an IL-15 antagonist but rather as an enhancer of IL-15-induced proinflammatory cytokines (IL-6, TNFα, and IL-17) that may promote tumor progression. This new tumor evasion mechanism based on amplification of the intratumoral inflammatory reaction is probably not restricted to head and neck cancer, as other tumors have been shown to release sIL-15Rα. Overall, these results support for the first time an original protumor role of sIL-15Rα in cancer.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-02442631 , version 1 (16-01-2020)

Identifiers

Cite

Cécile Badoual, Grégory Bouchaud, Nour El Houda Agueznay, Erwan Mortier, Stéphane Hans, et al.. The Soluble α Chain of Interleukin-15 Receptor: A Proinflammatory Molecule Associated with Tumor Progression in Head and Neck Cancer. Cancer Research, 2008, 68 (10), pp.3907 - 3921. ⟨10.1158/0008-5472.CAN-07-6842⟩. ⟨inserm-02442631⟩
38 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More